According to Renub Research latest report "China Oncology Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" China Cancer Drug Market is estimated to reach US$ 35.24 Billion by 2027. An estimated 9.6 million people died from cancer in 2018, making it the second highest cause of death worldwide. Approximately 1 in 6 deaths worldwide are attributed to cancer, according to figures released by the WHO. China, the most populated nation in the world, is experiencing a marked increase in cancer rates. According to the Global Cancer Observatory 2018, China has 4,285,033 new cancer cases yearly. After regulatory measures to streamline and encourage drug development, which also opened the way for increased investment by foreign pharmaceutical firms, China seems destined to become a major developer of cancer treatments within a few years.